Clarity Pharmaceuticals LTD (ASX: CU6)
Sector: Health Care
Market cap: A$586M (as of 2 Nov 2026)
Clarity is a clinical stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology.
Data as of 2 Nov 2026.
Recent capital raises
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 5 Oct 2026 | STATE STREET CORPORATION AND SUBSIDIARIES NAMED IN PARAGRAPH 7 TO THIS FORM | Entry | ?% → 5.25% | Filing ↗ |
| 25 Aug 2026 | Vanguard Group (The Vanguard Group, Inc. and its controlled entities including Vanguard Investments Australia Ltd. and those listed in Annexure A) | Entry | ?% → 5.075% | Filing ↗ |
| 7 July 2026 | Vanguard Group (The Vanguard Group, Inc. and its controlled entities including Vanguard Investments Australia Ltd. and those listed in Annexure A) | Exit | 5.0% → 4.751% | Filing ↗ |
| 25 June 2026 | Regal Partners Funds Management Pty Ltd and its associates (see Annexure 1) | Exit | — | Filing ↗ |
| 18 June 2026 | REGAL FUNDS MANAGEMENT PTY LIMITED AND ASSOCIATES | Increase | 5.96% → 7.11% | Filing ↗ |
Director trades — on-market
| Date | Director | Trade | Source |
|---|---|---|---|
| 20 Apr 2026 | Ms Michelle Kim Parker | Sold 360,896 | Filing ↗ |
| 20 May 2024 | Robert Bain Thomas | Bought 8,333 + 909 + 2,424 + 4,242 = 15,908 shares | Filing ↗ |
| 22 June 2022 | Charles Gillies O'Bryan-Tear | Bought 120,000 | Filing ↗ |
| 31 May 2022 | Dr Thomas Ramdahl | Bought 120,000 | Filing ↗ |
| 25 May 2022 | Robert Bain Thomas | Bought 100,000 shares | Filing ↗ |
Cash and runway
Ask about CU6 in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has CU6 raised money in the last year, and at what discount?
- What was CU6's latest cash position and runway?
Loading CU6…